| scholarly article | Q13442814 |
| P50 | author | Xing-Quan Zhu | Q60451763 |
| Dong-Hui Zhou | Q66905378 | ||
| Eskild Petersen | Q83389149 | ||
| P2093 | author name string | Bing Zhang | |
| Yong He | |||
| Xiu-Zhen Li | |||
| Rui-Qing Lin | |||
| Zi-Guo Yuan | |||
| Xian-Hui He | |||
| Xiu-Xiang Zhang | |||
| Xiao-Ru Shi | |||
| Xiu-Ling Zhong | |||
| Xu-Li Chen | |||
| P2860 | cites work | European Cytokine Network | Q27709360 |
| Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi | Q27710413 | ||
| The toxoplasma kinase ROP18: an active member of a degenerate family | Q28763605 | ||
| The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection | Q30758242 | ||
| Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. | Q32045346 | ||
| A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. | Q33591077 | ||
| Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. | Q33975360 | ||
| Gene therapy for infectious diseases | Q33992464 | ||
| DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice | Q34002934 | ||
| DNA vaccines: future strategies and relevance to intracellular pathogens | Q34570728 | ||
| A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii | Q34591236 | ||
| DNA vaccine strategies: candidates for immune modulation and immunization regimens. | Q35544636 | ||
| Toxoplasma gondii targets a protein phosphatase 2C to the nuclei of infected host cells. | Q35641036 | ||
| Toxoplasmic encephalitis in AIDS. | Q35810946 | ||
| Toxoplasmosis: the first commercial vaccine | Q35908289 | ||
| Toxoplasmosis in pregnancy | Q36060998 | ||
| DNA vaccines: progress and challenges | Q36186005 | ||
| Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue | Q37087502 | ||
| Polymorphic secreted kinases are key virulence factors in toxoplasmosis | Q37105671 | ||
| Mucosal immunity in mice induced by orally administered transgenic rice | Q37855753 | ||
| A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs | Q40014943 | ||
| Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein | Q40307471 | ||
| Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides | Q40512730 | ||
| Immunization of dogs and cats with a DNA vaccine against rabies virus | Q40818289 | ||
| Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii | Q43734277 | ||
| Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine. | Q43801623 | ||
| An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs | Q44025765 | ||
| Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice | Q44355445 | ||
| A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice | Q45391729 | ||
| MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis | Q45638880 | ||
| Protection in mice immunized with a heterologous prime-boost regime using DNA and recombinant pseudorabies expressing TgSAG1 against Toxoplasma gondii challenge | Q47840937 | ||
| Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii | Q48583196 | ||
| Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes | Q50789455 | ||
| [Studies on the immuno-protection of ROP2 nuclei acid vaccine in Toxoplasma gondii infection]. | Q53565880 | ||
| Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes. | Q53927474 | ||
| [Construction of monovalent and compound nucleic acid vaccines against Toxoplasma gondii with gene encoding p30]. | Q54652025 | ||
| Induction of immune responses in mice by vaccination with Liposome-entrapped DNA complexes encoding Toxoplasma gondii SAG1 and ROP1 genes | Q54747809 | ||
| Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice | Q63323106 | ||
| Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice | Q73074969 | ||
| Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris | Q79290975 | ||
| Role of IL-12 in HIV infection and vaccine | Q84762242 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Toxoplasma gondii | Q131003 |
| toxoplasmosis | Q154878 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 119-124 | |
| P577 | publication date | 2010-11-24 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice | |
| Protective Immunity Induced by Toxoplasma gondii Rhoptry Protein 16 against Toxoplasmosis in Mice | |||
| P478 | volume | 18 |
| Q28550486 | Boron Induces Lymphocyte Proliferation and Modulates the Priming Effects of Lipopolysaccharide on Macrophages |
| Q44839512 | DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice |
| Q22773213 | DNA vaccination with a gene encoding Toxoplasma gondii Rhoptry Protein 17 induces partial protective immunity against lethal challenge in mice |
| Q24471805 | Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii |
| Q33899385 | Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5. |
| Q34667736 | Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model |
| Q39412803 | Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model |
| Q50884140 | Evaluation of the Protective Effect of Deoxyribonucleic Acid Vaccines Encoding Granule Antigen 2 and 5 Against Acute Toxoplasmosis in BALB/c Mice. |
| Q55369116 | Identification of Antigenic and Immunogenic Proteins of Toxoplasma gondii in Human and Sheep by Immunoproteomics. |
| Q55397848 | Immune Protection of Rhoptry Protein 21 (ROP21) of Toxoplasma gondii as a DNA Vaccine Against Toxoplasmosis. |
| Q56567289 | Immunization With a DNA Vaccine Cocktail Encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 Genes Protects Mice Against Chronic Toxoplasmosis |
| Q36943560 | Induction of Protective Immunity against Toxoplasmosis in BALB/c Mice Vaccinated with Toxoplasma gondii Rhoptry-1. |
| Q36771638 | Interleukin-10 Serum Levels after Vaccination with In Vivo Prepared Toxoplasma gondii Excreted/Secreted Antigens. |
| Q35080048 | Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis |
| Q91345045 | Molecular characterization and protective immunity of rhoptry protein 35 (ROP35) of Toxoplasma gondii as a DNA vaccine |
| Q33812897 | New molecular tools in Neospora caninum for studying apicomplexan parasite proteins. |
| Q34257517 | Partial protective effect of intranasal immunization with recombinant Toxoplasma gondii rhoptry protein 17 against toxoplasmosis in mice |
| Q36505163 | Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice |
| Q35425382 | Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice |
| Q37119395 | Protective immune response in BALB/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondii |
| Q86031515 | Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice |
| Q38303517 | Recent advances in Toxoplasma gondii immunotherapeutics |
| Q61804925 | Rhoptry antigens as vaccine target |
| Q47105647 | Screening and Identification of the Host Proteins Interacting with Toxoplasma gondii Rhoptry Protein ROP16. |
| Q42367878 | Sixty Years (1957-2017) of Research on Toxoplasmosis in China-An Overview |
| Q42221098 | Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice |
| Q38740356 | Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice |
| Q45104207 | The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice |
| Q56769278 | Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis |
| Q40929777 | Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice |
| Q34271620 | Toxoplasma gondii: immune response and protective efficacy induced by ROP16/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2 |
| Q35940676 | Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii |
| Q38149266 | Vaccines against Toxoplasma gondii: new developments and perspectives |
Search more.